Levilimab Antibody
Levilimab (BCD-089) is a fully human monoclonal antibody designed to target and inhibit both membrane-bound and soluble interleukin-6 receptors (IL-6R) . It is utilized in rheumatoid arthritis research, supporting in vitro mechanistic studies and in vivo efficacy models to investigate IL-6 pathway blockade.
Product Specifications
Product Name Alternative
BCD089, BCD-089
Target
IL Receptor, Interleukin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
8.15 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.69 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog